Press releases

(French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer

Press release | 19 Jun 2012 - 16h36 | By INSERM PRESS OFFICE
Cancer

Sorry, this press release is only available in French.

TO CITE THIS POST :
Press release – Inserm press room (French) ADN tumoral circulant dans le sang : un nouveau biomarqueur du cancer Link : https://presse.inserm.fr/en/french-adn-tumoral-circulant-dans-le-sang-un-nouveau-biomarqueur-du-cancer/1831/

Other contents In the same category :

Cancer Voir tout

communi

A Vaccine to Overcome Immunotherapy Resistance

Researchers have shown that a commercially-available vaccine can overcome resistance to immunotherapy. Their study, published in Science Translational Medicine, shows that not only can gastroenteritis vaccines induce the immunogenic death of cancer cells in vitro, but also that combining them with immunotherapy ...
communi

Pediatric Cancers: Why Some Forms of Leukemia Only Affect Children

Acute myeloid leukemia (AML) mainly affects children, with the prognosis often being poor despite several decades of research into more effective treatments. A new study explains why some forms of leukemia develop in very young children. ...
fermer
fermer
RSS Youtube